Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States

被引：0
|
作者：
Jacob N. Hunnicutt
Mary Elizabeth Georgiou
Liyuan Ma
Roger A. Levy
Kerry Gairy
机构：
[1] GSK,
[2] Value Evidence and Outcomes,undefined
[3] GSK,undefined
[4] Value Evidence and Outcomes,undefined
[5] GSK,undefined
[6] Value Evidence and Outcomes,undefined
[7] GSK,undefined
[8] Global Medical Affairs,undefined
来源：
Rheumatology and Therapy | 2023年 / 10卷
关键词：
Corticosteroids; Induction treatment; Lupus nephritis; Maintenance treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1305 / 1318
页数：13
相关论文
共 50 条
  • [1] Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States
    Hunnicutt, Jacob N. N.
    Georgiou, Mary Elizabeth
    Ma, Liyuan
    Levy, Roger A. A.
    Gairy, Kerry
    RHEUMATOLOGY AND THERAPY, 2023, 10 (05) : 1305 - 1318
  • [2] Real-World Burden of Immunosuppressant-Treated Lupus Nephritis: A German Claims Database Analysis
    Garal-Pantaler, Elena
    Schultze, Michael
    Georgiou, Mary Elizabeth
    Pignot, Marc
    Gairy, Kerry
    Hunnicutt, Jacob N.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (01) : 113 - 127
  • [3] Real-World Burden of Immunosuppressant-Treated Lupus Nephritis: A German Claims Database Analysis
    Elena Garal-Pantaler
    Michael Schultze
    Mary Elizabeth Georgiou
    Marc Pignot
    Kerry Gairy
    Jacob N. Hunnicutt
    Rheumatology and Therapy, 2024, 11 : 113 - 127
  • [4] Rituximab in the real-world treatment of lupus nephritis: A retrospective cohort study in Japan
    Tanaka, Yoshiya
    Nakayamada, Shingo
    Yamaoka, Kunihiro
    Ohmura, Koichiro
    Yasuda, Shinsuke
    MODERN RHEUMATOLOGY, 2023, 33 (01) : 145 - 153
  • [5] Treatment Patterns and Health Care Costs of Lupus Nephritis in a United States Payer Population
    Bartels-Peculis, Laura
    Sharma, Ajay
    Edwards, Alison M.
    Sanyal, Anirudh
    Connolly-Strong, Erin
    Nelson, Winnie W.
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2020, 12 : 117 - 124
  • [6] Real-world electronic health record identifies antimalarial underprescribing in patients with lupus nephritis
    Xiong, W. W.
    Boone, J. B.
    Wheless, L.
    Chung, C. P.
    Crofford, L. J.
    Barnado, A.
    LUPUS, 2019, 28 (08) : 977 - 985
  • [7] Efficacy and safety of belimumab in patients with lupus nephritis: a real-world retrospective observational study
    Lin, Sishi
    Zhang, Ji
    You, Xiaohan
    Chen, Bo
    Liang, Yan
    Zhou, Yin
    Ding, Xiaokai
    Lv, Yinqiu
    Zhang, Huidi
    Su, Bofeng
    Bai, Yongheng
    Chen, Chaosheng
    RHEUMATOLOGY, 2024, 64 (02) : 614 - 622
  • [8] Efficacy and safety of telitacicept in patients with lupus nephritis: a single-center, real-world retrospective study
    Huang, Xiaolu
    Lin, Fuan
    Chen, Hongpu
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2024, 28 (09) : 902 - 909
  • [9] Belimumab versus telitacicept in sequential treatment after rituximab for refractory lupus nephritis: a real-world multicentre study
    Chen, Yiting
    Lei, Xin
    Xu, Jianhang
    Chen, Xiaochan
    Pan, Hong
    Zhang, Qiankun
    Wang, Junni
    Ren, Pingping
    Lan, Lan
    Shi, Nan
    Chen, Liangliang
    Wang, Yaomin
    Chen, Jianghua
    Jin, Lie
    Yang, Yi
    Xue, Jing
    Han, Fei
    LUPUS SCIENCE & MEDICINE, 2025, 12 (01):
  • [10] Efficacy, safety and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry
    Sakai, Hidenori
    Miyazaki, Yusuke
    Nakayamada, Shingo
    Kubo, Satoshi
    Hanami, Kentaro
    Fukuyo, Shunsuke
    Yamaguchi, Ayako
    Miyagawa, Ippei
    Ueno, Masanobu
    Tanaka, Hiroaki
    Todoroki, Yasuyuki
    Ohkubo, Naoaki
    Funada, Masashi
    Matsunaga, Satsuki
    Tanaka, Yoshiya
    RHEUMATOLOGY, 2024, : 1930 - 1939
12345